NO971110D0 - Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin - Google Patents

Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Info

Publication number
NO971110D0
NO971110D0 NO971110A NO971110A NO971110D0 NO 971110 D0 NO971110 D0 NO 971110D0 NO 971110 A NO971110 A NO 971110A NO 971110 A NO971110 A NO 971110A NO 971110 D0 NO971110 D0 NO 971110D0
Authority
NO
Norway
Prior art keywords
pallidipine
preparation
platelet aggregation
aggregation inhibitor
induced platelet
Prior art date
Application number
NO971110A
Other languages
English (en)
Other versions
NO971110L (no
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO971110D0 publication Critical patent/NO971110D0/no
Publication of NO971110L publication Critical patent/NO971110L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO971110A 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin NO971110L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en) 1994-09-12 1995-09-11 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number Publication Date
NO971110D0 true NO971110D0 (no) 1997-03-11
NO971110L NO971110L (no) 1997-05-07

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971110A NO971110L (no) 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Country Status (22)

Country Link
US (1) US5882887A (no)
EP (1) EP0781334A1 (no)
JP (1) JPH10505502A (no)
CN (1) CN1075836C (no)
AU (1) AU701643B2 (no)
BG (1) BG63276B1 (no)
BR (1) BR9508910A (no)
CA (1) CA2199719A1 (no)
CZ (1) CZ76297A3 (no)
FI (1) FI971013A0 (no)
HU (1) HU222398B1 (no)
IL (1) IL115272A0 (no)
MX (1) MX9701720A (no)
NO (1) NO971110L (no)
NZ (1) NZ293261A (no)
PL (1) PL184617B1 (no)
RO (1) RO117971B1 (no)
RU (1) RU2186110C2 (no)
SI (1) SI9520093A (no)
SK (1) SK29297A3 (no)
WO (1) WO1996008563A1 (no)
ZA (1) ZA957649B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774107B1 (en) * 1999-03-18 2004-08-10 Merck Patent Gmbh Protein for blocking platelet adhesion
CA2578072A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
WO2012172427A2 (en) * 2011-06-14 2012-12-20 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
KR102063195B1 (ko) 2012-02-07 2020-01-07 글로벌 바이오 테라퓨틱스, 인크. 핵산 전달의 구획화된 방법 및 이의 조성물 및 용도
MX2015002994A (es) 2012-09-07 2016-01-14 Inserm Inst Nat De La Santé Et De La Rech Médicale Peptidos de inhibidores obtenidos del receptor desencadenante expresado en celulas mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos.
US11364032B2 (en) 2013-08-08 2022-06-21 Global Bio Therapeutics, Inc. Clamp device for minimally invasive procedures and uses thereof
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
CN118139655A (zh) 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371041A1 (en) * 1987-06-24 1990-06-06 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
AU672584B2 (en) * 1991-09-05 1996-10-10 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
HU222398B1 (hu) 2003-06-28
AU701643B2 (en) 1999-02-04
HUT76972A (hu) 1998-01-28
CA2199719A1 (en) 1996-03-21
BR9508910A (pt) 1997-10-28
MX9701720A (es) 1997-06-28
PL319078A1 (en) 1997-07-21
US5882887A (en) 1999-03-16
CN1075836C (zh) 2001-12-05
AU3565795A (en) 1996-03-29
BG63276B1 (bg) 2001-08-31
SI9520093A (en) 1997-08-31
PL184617B1 (pl) 2002-11-29
NO971110L (no) 1997-05-07
FI971013A (fi) 1997-03-11
JPH10505502A (ja) 1998-06-02
CZ76297A3 (cs) 1998-01-14
WO1996008563A1 (en) 1996-03-21
IL115272A0 (en) 1995-12-31
ZA957649B (en) 1996-04-15
FI971013A0 (fi) 1997-03-11
CN1159828A (zh) 1997-09-17
SK29297A3 (en) 1997-10-08
BG101226A (en) 1998-10-30
EP0781334A1 (en) 1997-07-02
RU2186110C2 (ru) 2002-07-27
RO117971B1 (ro) 2002-11-29
NZ293261A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
IS1790B (is) Nýir hemlar á samsöfnun blóðflagna
NO180499C (no) Fremgangsmåte for pakking av en brönn
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
EE9800363A (et) Protsess asendatud sulfinüülheterotsükli magneesiumisoola valmistamiseks
PT101165A (pt) Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase
NO971110D0 (no) Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
EE9800109A (et) 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
NO972402D0 (no) Fremgangsmåte for fremstilling av bærere
NO306817B1 (no) Fremgangsmåte for fremstilling av aluminoksaner
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
NO179244C (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
PT91235A (pt) Processo para a preparacao de novos inibidores da s-adenosil-metionina-descarboxilase
BR9603088A (pt) Produto embalado
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi
NO985859D0 (no) FremgangsmÕte for fremstilling av Õpningsmidler for en forpakning
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
DE69520189D1 (de) Entfernung von Adsorbat
ZA965905B (en) New inhibitors of platelet aggregation
ES1028696Y (es) Expositor-suministrador de productos envasados.